FTC Chair Lina Khan’s Exit Interview: ‘I Hope We Don’t See Backsliding’
On the final days of her tenure as Federal Trade Commission chair, Lina Khan sits down with WSJ’s Damian Paletta to reflect ...
FTC Prepares to Sue Largest U.S. Apartment Landlord Over Hidden Fees
The FTC is weighing a lawsuit alleging Greystar failed to disclose fees related to trash services and background checks, ...
As Trump takes over, FTC’s Lina Khan says Big Tech scrutiny will persist
The Democratic enforcer significantly expanded the agency’s remit; now the new GOP administration will decide how to follow ...
After Meta Announcement, Lina Khan Urges Trump Not To Cut ‘Sweetheart Deals’ With Big Tech
The outgoing chair of the Federal Trade Commission believes Meta and other companies are hoping that favors for the president ...
Federal Trade Commission accuses Greystar of deceptive practices, hidden fees
The antitrust agency recently created a rule regarding junk fees, but its application to the multifamily sector is unclear.
Musk’s Lawsuit Against OpenAI Gets a Boost From Lina Khan’s FTC
While they didn't support Musk's allegations directly, the feds added weight to his interpretation of antitrust law.
Federal Trade Commission sets closed door meeting for next Thursday
The Federal Trade Commission has scheduled a closed-door meeting for next Thursday as FTC Chair Lina Khan's reign nears an ...
FTC’s Khan Urges Agency to ‘Stay Aggressive’ After She Goes
Only seven working days remain in the Biden administration, but US Federal Trade Commission Chair Lina Khan still hopes to ...
PBMs made billions marking up speciality drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
Fierce Healthcare8h
FTC: Big 3 PBMs generated $7.3B from specialty generic drug markups
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...
FTC alleges PBMs cost consumers $7.3 billion marking up drug prices
The FTC released a 60-page report Tuesday targeting the biggest three pharmacy benefit managers, claiming the companies hiked the prices of specialty drugs to generate $7.3 billion in revenue from ...
Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...